Nitazoxanide DT 200 mg (Generic) – Dispersible Antiparasitic Tablet
Buy Nitazoxanide DT 200 mg (Generic) from Tabexports – Worldwide Pharmaceutical Exporter
Nitazoxanide DT 200 mg (Generic) is a dispersible antiparasitic tablet used in the management of protozoal and certain intestinal parasitic infections. The DT (Dispersible Tablet) formulation allows easy administration, especially for pediatric and patient-friendly dosing, when used under medical supervision.
Tabexports supplies Nitazoxanide DT 200 mg tablets for bulk and wholesale export, offering export-compliant packaging, competitive pricing, and reliable worldwide logistics support.
Active Ingredient
Nitazoxanide 200 mg
Nitazoxanide works by inhibiting anaerobic energy metabolism in parasites, preventing their growth and survival.
Product Highlights
✔ Nitazoxanide 200 mg dispersible tablet
✔ Generic antiparasitic formulation
✔ Suitable for protozoal & intestinal parasitic infections (as prescribed)
✔ Easy-to-administer DT formulation
✔ Export-ready international packaging
✔ Bulk & wholesale supply available worldwide
Mechanism of Action
Nitazoxanide acts by:
-
Inhibiting pyruvate:ferredoxin oxidoreductase–dependent pathways
-
Disrupting parasite energy metabolism
-
Preventing parasite replication and survival
Use strictly under professional medical guidance.
Dosage & Administration
-
Take as prescribed by a licensed healthcare professional
-
Disperse tablet in water before administration
-
Dosage depends on age, weight, and infection type
-
Complete the full prescribed course
-
Do not exceed recommended dosage
Storage & Safety Information
-
Store in a cool, dry place
-
Protect from moisture and direct sunlight
-
Keep out of reach of children
-
Use only under medical supervision
Why Choose Tabexports?
🌍 Trusted global pharmaceutical exporter
📦 Export-grade packaging & regulatory documentation
🚚 Reliable worldwide shipping network
🏭 Quality-focused sourcing standards
📈 Bulk supply & long-term global distribution partnerships





Reviews
There are no reviews yet.